A timely piece on Labor Market Monopsony and the American
Business Sector from the NYTIMES:
Declining Competition in the Corporate Sector - a major
problem for the US economy:
http://www.nytimes.com/2016/11/02/business/economy/how-waning-competition-deepens-labors-plight.html
A Cure for Swelling Drug Prices: Competition: Free
trade in generics could curb near-monopolies wielded by the likes of EpiPen’s
maker by Greg Ip (WSJ)
“As it happens, even among generics, business
circumstances and regulation can conspire to give one supplier a monopoly it is
happy to exploit. Ideally, this should be met not with price controls, but more
competition—from home and abroad. If the U.S. allowed the sale of drugs that
regulators in other advanced countries have already approved, it would expose
would-be monopolists to many more potential competitors.”
Related –
Market Power and Pricing Power
http://vivekjayakumar.blogspot.com/2016/09/market-power-and-pricing-power.html